stars 1 stars 2 stars 3

The data- and biobank Acutelines is initiated to improve recognition and treatment of acute diseases and obtain insight in the consequences of acute diseases, including factors predicting its outcome. To reach these aims, we will collect health data and biomaterial (blood, urine, stool) of patients visiting the emergency department of the University Medical Center Groningen (UMCG). Subsequently, additional data is collected describing the development of the acute disease in hospital, as well as during long-term follow-up after hospital discharge. Currently, little is known about the specific causes and consequences of acute illnesses. Through Acutelines, both of these questions can be researched. In this way we will be able to optimize patient treatment and be able to better predict patient outcomes after an acute admission. Collected information and biomaterials will be made available for other researchers.

Acutelines Questions

The Acutelines annual revenue was $2.1 billion in 2026.

6 people are employed at Acutelines.

Top Acutelines Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users